Renascent Diagnostics, LLC
Burlington, VT, US· latest recorded location
Renascent Diagnostics, LLC is named on 2 US grants and 3 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 2
- Published applications
- 3
- Inventors
- 2
- Granted in 2026 so far
- 1
- Most recent grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 5 documents
Recent patents
- System and method for detecting a target bacteria25 Aug 2026US 12,716,827 B2
- Methods and systems for increasing the capacity of flow cytometer bacteria detection and antibiotic susceptibility testing systems14 Feb 2023US 11,579,069 B2
- Method and systems for increasing the capacity of flow cytometter bacteria detection and antibiotic susceptibility testing systems20 Jul 2023US 2023/0227768 A1
- System and method for detecting a target bacteria16 Mar 2023US 2023/0082300 A1
- Methods And Systems For Increasing The Capacity Of Flow Cytometer Bacteria Detection And Antibiotic Susceptibility Testing Systems6 Aug 2020US 2020/0249144 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.